查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1874006

細胞療法市場

Cell Therapy Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

細胞治療市場預計將從 2024 年的 102.8 億美元成長到 2031 年的 167.2 億美元，2031 年至 2031 年的年複合成長率(CAGR) 為 7.2%。推動該市場成長的關鍵趨勢包括細胞療法的進步以及領先製造商推出創新產品。

細胞療法市場分析

再生療法促進細胞、組織和器官的再生，從而幫助恢復其功能。根據再生醫學聯盟報告，截至2023年第四季度，全球共有520項涉及細胞療法藥物的臨床試驗（包括192項I期臨床試驗、125項II期臨床試驗及36項III期臨床試驗）。 2017年，Kymriah獲批上市，成為首個獲批上市的細胞療法，這標誌著細胞療法在細胞和基因治療領域的重要地位得到了顯著提升。 CAR-T細胞（嵌合抗原受體T細胞）療法的出現徹底改變了癌症的治療方法。 CAR-T細胞療法經歷了廣泛的研究和創新，目前已有五種產品——Yescarta、Abecma、Tecartus、Breyanzi和Carvykti——獲準用於治療多種血液癌症。因此，再生醫學應用的不斷擴展正在推動細胞療法市場的成長。

細胞治療市場概覽

CAR-T細胞療法已成為一種極具前景的癌症治療手段。每年都有大量的臨床前和臨床試驗開展，以探索其在新的治療應用中的潛力。未來的研究預計將聚焦於自體和異體CAR-T細胞產品，以及新型體內CAR-T細胞基因療法及其在血液系統惡性腫瘤以外疾病的療效。

戰略洞察

細胞治療市場的促進因素與機遇

癌症發生率上升推動市場擴張

久坐的生活方式和飲食習慣的改變等因素被認為是多種慢性疾病的重要風險因素，包括神經系統疾病、癌症、自體免疫疾病和心血管疾病。美國疾病管制與預防中心報告稱，十分之六的美國人患有一種或多種慢性疾病，包括糖尿病、癌症、心臟病或中風。慢性疾病是美國死亡和殘疾的主要原因。遺傳傾向、加工食品、污染和生活方式的改變等因素導致癌症發生率不斷上升。美國癌症協會指出，2020年全球新增癌症病例近1,930萬例。近幾十年來，細胞療法作為一種新型癌症治療方法興起，其原理是在實驗室中改造T細胞，然後用於靶向癌細胞。 CAR-T細胞療法已用於治療成人和兒童白血病以及某些類型的淋巴瘤，目前正在研究其治療其他癌症（包括實體瘤）的潛力。因此，癌症患者數量的不斷成長推動了對CAR-T細胞療法的需求，從而促進了細胞療法市場的成長。

研發經費

鑑於先前接受過治療的複發/難治性惡性腫瘤患者中細胞療法的完全緩解率和無進展生存期顯著提高，研究人員正致力於探索提升細胞療法療效的方法。目前正在研究抗原流失等可能導致免疫逃脫的因素，並制定應對這些挑戰的策略。一個很有前景的方法是設計能夠同時針對多種抗原的細胞療法。加州再生醫學研究所 (CIRM) 是全球最大的再生醫學機構，已撥款 4,380 萬美元用於支持加州的基因治療和幹細胞研究項目，資助該研究所的臨床、發現和基礎設施建設等多個項目。

細胞治療市場區隔分析

細胞治療市場分析的關鍵細分市場包括治療類型、產品、技術、應用和最終用戶。

  • 細胞治療市場按治療類型分為同種異體和自體，到 2023 年，同種異體部分將佔據更大的市場佔有率。
  • 按產品分類，市場分為耗材、設備、系統和軟體，其中設備部分在 2023 年佔據市場佔有率領先地位。
  • 從技術角度來看，市場涵蓋病毒載體技術、基因組編輯技術、體細胞技術、細胞永生化技術、細胞可塑性技術和3D技術。
  • 按應用領域分類，市場分為腫瘤學、心血管、骨科、傷口管理和其他應用領域，其中腫瘤學在 2023 年佔據最大的市場佔有率。
  • 根據最終用戶分類，細胞治療市場分為研究機構、醫院和其他機構，其中醫院在 2023 年佔據了市場佔有率的主導地位。

細胞治療市場的地理分析

細胞療法市場報告的地理範圍分為五個地區：北美、亞太、歐洲、中東和非洲以及南美和中美洲。北美市場領先，其中美國在2023年佔據最大佔有率。這一成長歸功於研發投入的增加，以及幹細胞療法、基因療法和免疫療法等細胞療法日益普及的現象。遺傳和細胞疾病發生率的上升，以及對提升細胞療法研發和生產能力的重視，進一步推動了市場成長。拜耳公司在柏克萊建立了其首個細胞療法上市中心，旨在為全球患者提供細胞療法。這座耗資2.5億美元、佔地10萬平方英尺的設施將為後期臨床試驗提供材料，以促進bemdaneprocel（BRT-DA01）的商業化上市。 bemdaneprocel是由BlueRock Therapeutics公司研發的一種用於治療帕金森氏症和其他疾病的實驗性細胞療法。預計在預測期內，亞太地區的細胞療法市場複合年成長率將最高。

細胞療法市場報告範圍

細胞治療市場最新動態

細胞治療市場的評估是基於從一手和二手研究中獲得的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。細胞治療市場近期的一些發展包括：

  • 專注於建立領先的細胞編程和生物安全平台的Ginkgo Bioworks公司宣布收購Modulus Therapeutics的細胞治療平台資產，其中包括其CAR和轉換受體庫。 （資料來源：Ginkgo Bioworks公司，新聞稿，2024）
  • 阿斯特捷利康已達成最終協議，收購全球臨床階段生物製藥公司Gracell Biotechnologies Inc.，該公司致力於開發用於治療癌症和自體免疫疾病的創新細胞療法。 （資料來源：阿斯特捷利康公司，新聞稿，2024年）

細胞療法市場報告的覆蓋範圍和成果

這份題為《細胞療法市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 細胞治療市場規模及預測，涵蓋全球、區域和國家層面的所有主要市場細分領域。
  • 細胞治療市場的發展趨勢以及市場動態，例如促進因素、限制因素和關鍵機會。
  • 深入的 PEST/波特五力模型和 SWOT 分析。
  • 對細胞治療市場進行分析，涵蓋關鍵趨勢、全球和區域框架、主要參與者、法規和近期市場發展。
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者以及細胞治療市場的最新發展。
  • 市場主要公司的詳細概況。

目錄

第1章：引言

第2章：細胞療法市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：全球細胞療法及市場概況

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 歐洲PEST分析
    • 亞太地區及PEST分析
    • 中東和非洲以及 PEST 分析
    • 南美洲和中美洲以及 PEST 分析
  • 專家意見

第5章：全球細胞治療市場及關鍵產業動態

  • 主要市場促進因素
    • 慢性病盛行率不斷上升
    • 再生醫學的日益普及
    • 細胞療法獲準數量不斷增加
  • 主要市場限制因素
    • 細胞療法生產成本高昂
  • 主要市場機遇
    • 發展中地區細胞療法的普及率不斷提高
  • 未來趨勢
    • 向自動化細胞治療生產轉型
  • 駕駛員和約束裝置的影響分析

第6章：細胞療法市場及全球分析

  • 全球細胞療法市場收入預測與分析
  • 全球細胞治療市場（依地域分類）－預測與分析
  • 市場定位

第7章：細胞療法市場分析及依療法類型分類

  • 概述
  • 細胞療法市場收入佔有率（按療法類型分類，2024 年和 2031 年）
  • 同種異體
  • 自體

第8章：細胞療法市場分析及產品分類

  • 概述
  • 細胞療法市場收入佔有率（按產品分類，2024 年和 2031 年）
  • 消耗品
  • 裝置
  • 系統和軟體

第9章：細胞療法市場分析及技術分類

  • 概述
  • 按技術分類的細胞療法市場收入佔有率（2024 年和 2031 年）
  • 病毒載體技術
  • 基因組編輯技術
  • 體細胞技術
  • 細胞永生化技術
  • 細胞可塑性技術
  • 3D技術

第10章：細胞療法市場分析及應用

  • 概述
  • 細胞療法市場收入佔有率（按應用領域分類，2024 年和 2031 年）
  • 腫瘤學
  • 心血管
  • 骨科
  • 傷口管理
  • 其他應用

第11章：細胞療法市場分析及最終用戶分類

  • 概述
  • 細胞療法市場佔有率（按最終用戶分類），2024 年和 2031 年（%）
  • 醫院
  • 研究機構
  • 其他

第12章：細胞療法市場及地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第13章：新冠疫情對全球細胞治療市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 中東和非洲
  • 南美洲和中美洲

第14章：細胞療法市場及產業概況

  • 概述
  • 市場中各公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機物發展
    • 概述

第15章：公司簡介

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc.
  • Mesoblast Limited
  • JCR Pharmaceuticals Co. Ltd.
  • Smith and Nephew
  • Bristol-Myers Squibb Company
  • Cells for Cells
  • Stemedica Cell Technologies, Inc
  • Castle Creek Biosciences, Inc.

第16章：附錄

簡介目錄
Product Code: TIPRE00009666

The cell therapy market is anticipated to grow from US$ 10.28 billion in 2024 to US$ 16.72 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.2% during the period from 2031 to 2031. Key trends driving this market include advancements in cell-based therapeutics and the launch of innovative products by leading manufacturers.

Analysis of the Cell Therapy Market

Regenerative therapies promote the regeneration of cells, tissues, and organs, facilitating the restoration of their functions. As reported by the Alliance for Regenerative Medicine, there were 520 clinical trials involving cell therapy medicines globally as of Q4 2023 (comprising 192 Phase I, 125 Phase II, and 36 Phase III trials). The approval and commercialization of Kymriah in 2017, the first of its kind in cell therapy, marked a pivotal moment that has bolstered the significance of cell therapy within the cell and gene therapy sector. The advent of CAR-T cell (chimeric antigen receptor T cell) therapy has revolutionized cancer treatment approaches. CAR-T cell therapies have seen extensive research and innovation, with five additional products-Yescarta, Abecma, Tecartus, Breyanzi, and Carvykti-receiving approval for various blood cancers. Consequently, the expanding applications of regenerative medicine are propelling the growth of the cell therapy market.

Overview of the Cell Therapy Market

CAR T-cell therapy has emerged as a promising cancer treatment modality. Each year, numerous preclinical and clinical trials are conducted to explore its potential in new therapeutic applications. Future research is expected to focus on both autologous and allogeneic products, as well as new in-vivo CAR-T cell gene therapies and their effectiveness in conditions beyond hematologic malignancies.

Strategic Insights

Drivers and Opportunities in the Cell Therapy Market

Rising Cancer Prevalence Fuels Market Expansion

Factors such as sedentary lifestyles and dietary changes are recognized as significant risk factors for chronic diseases, including neurological disorders, cancer, autoimmune diseases, and cardiovascular diseases. The Centers for Disease Control and Prevention reports that 6 out of 10 Americans are affected by one or more chronic illnesses, including diabetes, cancer, heart disease, or stroke. Chronic diseases are leading causes of death and disability in the US. Factors like genetic predisposition, processed foods, pollution, and lifestyle changes contribute to the increasing incidence of cancer. The American Cancer Society noted nearly 19.3 million new cancer cases worldwide in 2020. In recent decades, cell therapy has emerged as a novel cancer treatment approach, where T cells are modified in a lab and then administered to target cancer cells. CAR-T cell therapy is utilized for treating adult and pediatric leukemia and certain types of lymphoma, with ongoing research into its potential for treating other cancers, including solid tumors. Thus, the rising number of cancer patients is driving demand for CAR-T cell therapies, contributing to the growth of the cell therapy market.

Funding for Research and Development

Researchers are driven to explore ways to enhance the efficacy of cell therapy, particularly given the complete response rates and progression-free survival seen in patients with relapsed/refractory malignancies who have undergone prior treatments. Investigations into factors like antigen loss that may lead to immune escape are underway, with strategies being developed to address these challenges. One promising approach involves designing cell therapies that target multiple antigens simultaneously. The California Institute for Regenerative Medicine (CIRM), the largest regenerative medicine organization globally, has allocated US$ 43.8 million to support gene therapy and stem cell research initiatives in California, funding projects across clinical, discovery, and infrastructure programs of the institute.

Segmentation Analysis of the Cell Therapy Market

Key segments contributing to the analysis of the cell therapy market include therapy type, product, technology, application, and end user.

  • The cell therapy market is categorized by therapy type into allogeneic and autologous, with the allogeneic segment holding a larger market share in 2023.
  • By product, the market is divided into consumables, equipment, and systems and software, with the equipment segment leading the market share in 2023.
  • In terms of technology, the market encompasses viral vector technology, genome editing technology, somatic cell technology, cell immortalization technology, cell plasticity technology, and three-dimensional technology.
  • By application, the market is segmented into oncology, cardiovascular, orthopedic, wound management, and other applications, with oncology holding the largest market share in 2023.
  • Based on end user, the cell therapy market is classified into research institutes, hospitals, and others, with hospitals dominating the market share in 2023.

Geographical Analysis of the Cell Therapy Market

The geographical scope of the cell therapy market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. North America leads the market, with the US holding the largest share in 2023. This growth is attributed to increased research and development, along with the rising adoption of cell therapies such as stem cell, gene, and immune therapies. The growing incidence of genetic and cellular disorders, coupled with a focus on enhancing the development and manufacturing capacities of cell therapies, further supports market growth. Bayer AG has established its first Cell Therapy Launch Facility in Berkeley, aimed at delivering cell therapies to patients globally. This US$ 250 million, 100,000-square-foot facility will provide materials for late-stage clinical trials to facilitate the commercial launch of bemdaneprocel (BRT-DA01), an experimental cell therapy being tested by BlueRock Therapeutics for Parkinson's disease and other conditions. The Asia Pacific region is expected to exhibit the highest CAGR in the cell therapy market during the forecast period.

Scope of the Cell Therapy Market Report

Recent Developments in the Cell Therapy Market

The evaluation of the cell therapy market is based on qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Some recent developments in the cell therapy market include:

  • Ginkgo Bioworks, a company focused on building a leading platform for cell programming and biosecurity, announced the acquisition of Modulus Therapeutics' cell therapy platform assets, which include their CAR and switch receptor libraries. (Source: Ginkgo Bioworks Company Name, Press Release, 2024)
  • AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company that develops innovative cell therapies for cancer and autoimmune diseases. (Source: AstraZeneca Company Name, Press ReleaseNewsletter, 2024)

Coverage and Deliverables of the Cell Therapy Market Report

The report titled "Cell Therapy Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Cell therapy market size and forecast at global, regional, and country levels for all key market segments included in the scope.
  • Trends in the cell therapy market along with market dynamics such as drivers, restraints, and key opportunities.
  • In-depth PEST/Porter's Five Forces and SWOT analysis.
  • Analysis of the cell therapy market covering key trends, global and regional frameworks, major players, regulations, and recent market developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments in the cell therapy market.
  • Detailed profiles of key companies in the market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cell Therapy Market and By Therapy Type
    • 1.3.2 Global Cell Therapy Market and By Product
    • 1.3.3 Global Cell Therapy Market and By Technology
    • 1.3.4 Global Cell Therapy Market and By Application
    • 1.3.5 Global Cell Therapy Market and By End User
    • 1.3.6 Global Cell Therapy Market and By Geography

2. Cell Therapy Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cell therapyand Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europeand PEST Analysis
    • 4.2.3 Asia Pacificand PEST Analysis
    • 4.2.4 Middle East and Africa and PEST Analysis
    • 4.2.5 South and Central America and PEST Analysis
  • 4.3 Expert Opinions

5. Global Cell Therapy Market and Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Rising Adoption of Regenerative Medicines
    • 5.1.3 Increasing Number of Approvals for Cell-Based Therapies
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Cell Therapy Manufacturing
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
  • 5.4 Future Trends
    • 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
  • 5.5 Impact Analysis of Drivers and Restraints

6. Cell therapy Market and Global Analysis

  • 6.1 Global Cell therapy Market Revenue Forecast And Analysis
  • 6.2 Global Cell therapy Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning

7. Cell therapy Market Analysis and By Therapy Type

  • 7.1 Overview
  • 7.2 Cell therapy Market Revenue Share, by Therapy Type (2024 and 2031)
  • 7.3 Allogeneic
    • 7.3.1 Overview
    • 7.3.2 Allogeneic: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Autologous
    • 7.4.1 Overview
    • 7.4.2 Autologous: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

8. Cell therapy Market Analysis and By Product

  • 8.1 Overview
  • 8.2 Cell therapy Market Revenue Share, by Product (2024 and 2031)
  • 8.3 Consumables
    • 8.3.1 Overview
    • 8.3.2 Consumables: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Equipment
    • 8.4.1 Overview
    • 8.4.2 Equipment: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Systems and Software
    • 8.5.1 Overview
    • 8.5.2 Systems and Software: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

9. Cell therapy Market Analysis and By Technology

  • 9.1 Overview
  • 9.2 Cell therapy Market Revenue Share, by Technology (2024 and 2031)
  • 9.3 Viral Vector Technology
    • 9.3.1 Overview
    • 9.3.2 Viral Vector Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Genome Editing Technology
    • 9.4.1 Overview
    • 9.4.2 Genome Editing Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Somatic Cell Technology
    • 9.5.1 Overview
    • 9.5.2 Somatic Cell Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Cell Immortalization Technology
    • 9.6.1 Overview
    • 9.6.2 Cell Immortalization Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Cell Plasticity Technology
    • 9.7.1 Overview
    • 9.7.2 Cell Plasticity Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Three-Dimensional Technology
    • 9.8.1 Overview
    • 9.8.2 Three-Dimensional Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

10. Cell therapy Market Analysis and By Application

  • 10.1 Overview
  • 10.2 Cell therapy Market Revenue Share, by Application (2024 and 2031)
  • 10.3 Oncology
    • 10.3.1 Overview
    • 10.3.2 Oncology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Cardiovascular
    • 10.4.1 Overview
    • 10.4.2 Cardiovascular: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Orthopedic
    • 10.5.1 Overview
    • 10.5.2 Orthopedic: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Wound Management
    • 10.6.1 Overview
    • 10.6.2 Wound Management: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.7 Other Applications
    • 10.7.1 Overview
    • 10.7.2 Other Applications: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

11. Cell therapy Market Analysis and By End User

  • 11.1 Overview
  • 11.2 Cell therapy Market Share, by End User, 2024 and 2031, (%)
  • 11.3 Hospitals
    • 11.3.1 Overview
    • 11.3.2 Hospitals: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Research Institutes
    • 11.4.1 Overview
    • 11.4.2 Research Institutes: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

12. Cell therapy Market and Geographic Analysis

  • 12.1 North America: Cell Therapy Market
    • 12.1.1 Overview
    • 12.1.2 North America: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.3 North America: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.1.4 North America: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.1.5 North America: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.1.6 North America: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.1.7 North America: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.1.8 North America: Cell Therapy Market, by Country, 2024 and 2031 (%)
    • 12.1.9 US: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.1 US: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.2 US: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.3 US: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.4 US: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.5 US: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.6 US: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10 Canada: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.1 Canada: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.2 Canada: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.3 Canada: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.4 Canada: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.5 Canada: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.6 Canada: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11 Mexico: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.1 Mexico: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.2 Mexico: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.3 Mexico: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.4 Mexico: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.5 Mexico: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.6 Mexico: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.2 Europe: Cell therapy Market
    • 12.2.1 Overview
    • 12.2.2 Europe: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.3 Europe: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.2.4 Europe: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.2.5 Europe: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.2.6 Europe: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.2.7 Europe: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.8 Europe: Cell therapy Market, by Country, 2024 and 2031 (%)
    • 12.2.9 Germany: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.1 Germany: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.2 Germany: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.3 Germany: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.4 Germany: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.5 Germany: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.6 Germany: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10 France: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.1 France: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.2 France: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.3 France: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.4 France: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.5 France: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.6 France: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11 UK: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.1 UK: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.2 UK: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.3 UK: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.4 UK: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.5 UK: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.6 UK: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12 Italy: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.1 Italy: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.2 Italy: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.3 Italy: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.4 Italy: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.5 Italy: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.6 Italy: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13 Spain: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.1 Spain: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.2 Spain: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.3 Spain: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.4 Spain: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.5 Spain: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.6 Spain: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.3 Asia Pacific: Cell Therapy Market
    • 12.3.1 Overview
    • 12.3.2 Asia Pacific: Cell Therapy Market - Revenue and Forecast to 2031 (USD Million)
    • 12.3.3 Asia Pacific: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.3.4 Asia Pacific: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.3.5 Asia Pacific: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.3.6 Asia Pacific: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.3.7 Asia Pacific: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.8 Asia Pacific: Cell Therapy Market, by Country, 2024 and 2031 (%)
    • 12.3.9 China: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.9.1 China: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.9.2 China: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.9.3 China: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.9.4 China: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.9.5 China: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.9.6 China: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.10 Japan: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.10.1 Japan: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.10.2 Japan: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.10.3 Japan: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.10.4 Japan: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.10.5 Japan: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.10.6 Japan: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.11 India: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.11.1 India: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.11.2 India: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.11.3 India: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.11.4 India: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.11.5 India: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.11.6 India: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.12 South Korea: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.12.1 South Korea: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.12.2 South Korea: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.12.3 South Korea: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.12.4 South Korea: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.12.5 South Korea: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.12.6 South Korea: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.13 Australia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.13.1 Australia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.13.2 Australia: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.13.3 Australia: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.13.4 Australia: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.13.5 Australia: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.13.6 Australia: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.4 Middle East and Africa: Cell Therapy Market
    • 12.4.1 Overview
    • 12.4.2 Middle East and Africa: Cell Therapy Market - Revenue and Forecast to 2031 (USD Million)
    • 12.4.3 Middle East and Africa: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
    • 12.4.4 Middle East and Africa: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
    • 12.4.5 Middle East and Africa: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
    • 12.4.6 Middle East and Africa: Cell Therapy Market, by Application, 2018and2031 (USD Million)
    • 12.4.7 Middle East and Africa: Cell Therapy Market, by End-User, 2018and2031 (USD Million)
    • 12.4.8 Middle East and Africa: Cell Therapy Market, by Country, 2019 and 2031 (%)
    • 12.4.9 UAE: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.9.1 UAE: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.9.2 UAE: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
      • 12.4.9.3 UAE: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
      • 12.4.9.4 UAE: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
      • 12.4.9.5 UAE: Cell Therapy Market, by Application, 2018and2031 (USD Million)
      • 12.4.9.6 UAE: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.4.10 Saudi Arabia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.10.1 Saudi Arabia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.10.2 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
      • 12.4.10.3 Saudi Arabia: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
      • 12.4.10.4 Saudi Arabia: Cell Therapy Market, by Technology, 2018and2031 (USD Millions)
      • 12.4.10.5 Saudi Arabia: Cell Therapy Market, by Application, 2018and2031 (USD Million)
      • 12.4.10.6 Saudi Arabia: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.4.11 South Africa: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.11.1 South Africa: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.11.2 South Africa: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
      • 12.4.11.3 South Africa: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.4.11.4 South Africa: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
      • 12.4.11.5 South Africa: Cell Therapy Market, by Application, 2018and2031 (USD Million)
      • 12.4.11.6 South Africa: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.5 South and Central America: Cell Therapy Market
    • 12.5.1 Overview
    • 12.5.2 South and Central America: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.5.3 South and Central America: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.5.4 South and Central America: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.5.5 South and Central America: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.5.6 South and Central America: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.5.7 South and Central America: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.5.8 South and Central America: Cell Therapy Market, by Country, 2024 and 2031 (%)
    • 12.5.9 Brazil: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.9.1 Brazil: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.9.2 Brazil: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.5.9.3 Brazil: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.5.9.4 Brazil: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.5.9.5 Brazil: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.5.9.6 Brazil: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.5.10 Argentina: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.10.1 Argentina: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.10.2 Argentina: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.5.10.3 Argentina: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.5.10.4 Argentina: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.5.10.5 Brazil: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.5.10.6 Brazil: Cell Therapy Market, by End User, 2018and2031 (USD Million)

13. Impact of COVID-19 Pandemic on Global Cell Therapy Market

  • 13.1 North America: Impact Assessment of COVID-19 Pandemic
  • 13.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Cell Therapy Marketand Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies Done by the Companies in the Market, (%)
  • 14.3 Organic Developments
    • 14.3.1 Overview
  • 14.4 Inorganic Developments
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Vericel Corporation
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 MEDIPOST
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 NuVasive, Inc.
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Mesoblast Limited
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 JCR Pharmaceuticals Co. Ltd.
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Smith and Nephew
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Bristol-Myers Squibb Company
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Cells for Cells
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Stemedica Cell Technologies, Inc
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Castle Creek Biosciences, Inc.
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms